Pfizer Hires Glaxo Executive as Senior VP
January 31, 2011
According to the Associated Press, Pfizer Inc. has named Dr. Yvonne Greenstreet as the senior vice president and head of medicine development for the specialty care business unit, effective Tuesday. Greenstreet will replace Dr. Michael Berelowitz, who is retiring. Greenstreet joins Pfizer from British drugmaker GlaxoSmithKline, where she was senior vice president and chief of strategy, research and development.